Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Orchid Pharma Profit & Loss Annual
Trade1,508.25 +49.15 (3.37%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 819.37 | 665.90 | 559.56 | 450.06 |
| Total Revenue | 819.37 | 665.90 | 559.56 | 450.06 |
| Costof Revenue Total | 484.46 | 458.44 | 313.56 | 228.50 |
| Gross Profit | 334.91 | 207.46 | 246.00 | 221.56 |
| Selling/ General/ Admin Expenses Total | 69.64 | 117.32 | 63.28 | 67.11 |
| Depreciation/ Amortization | 33.24 | 54.79 | 87.02 | 108.92 |
| Other Operating Expenses Total | 154.59 | - | 129.59 | 104.67 |
| Total Operating Expense | 741.93 | 597.70 | 593.45 | 509.20 |
| Operating Income | 77.44 | 68.20 | -33.89 | -59.14 |
| Interest Inc( Exp) Net- Non- Op Total | -163.55 | -87.51 | -185.95 | -390.30 |
| Other Net | 30.86 | -4.98 | -4.41 | 2.91 |
| Net Income Before Taxes | 91.95 | 55.25 | -56.90 | -95.25 |
| Provisionfor Income Taxes | -3.12 | 0.00 | 0.00 | 0.00 |
| Net Income After Taxes | 95.06 | 55.25 | -56.90 | -95.25 |
| Equity In Affiliates | -28.98 | -21.54 | -35.23 | - |
| Net Income Before Extra Items | 92.17 | 53.09 | -60.42 | -95.25 |
| Net Income | 92.17 | 46.32 | -1.95 | -116.53 |
| Income Availableto Com Excl Extra Ord | 92.17 | 53.09 | -60.42 | -95.25 |
| Income Availableto Com Incl Extra Ord | 92.17 | 46.32 | -1.95 | -116.53 |
| Diluted Net Income | 92.17 | 46.32 | -1.95 | -116.53 |
| Diluted Weighted Average Shares | 4.84 | 4.08 | 4.08 | 4.08 |
| Diluted EPS Excluding Extra Ord Items | 19.06 | 13.01 | -14.80 | -23.34 |
| Diluted Normalized EPS | 19.06 | 3.21 | -14.80 | -23.34 |
| Research Development | - | 63.62 | - | - |
| Unusual Expense( Income) | - | -39.21 | 0.00 | 0.00 |
| Gain( Loss)on Saleof Assets | - | 7.75 | 0.00 | 0.14 |
| Total Extraordinary Items | - | -6.78 | 58.47 | -21.28 |
*All figures in crores except per share values
Orchid Pharma Quick Links
Orchid Pharma Dividend Orchid Pharma Bonus Orchid Pharma News Orchid Pharma AGM Orchid Pharma Rights Orchid Pharma Splits Orchid Pharma Board Meetings Orchid Pharma Key Metrics Orchid Pharma Shareholdings Orchid Pharma Balance Sheet Orchid Pharma Cashflow Orchid Pharma Q1 Results Orchid Pharma Q2 Results Orchid Pharma Q3 Results Orchid Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)